452
Views
5
CrossRef citations to date
0
Altmetric
Articles

Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising

ORCID Icon, , , &

References

  • Ahn, H. Y. A., Park, J. S., & Haley, E. (2014). Consumers’ optimism bias and responses to risk disclosures in Direct‐to‐Consumer (DTC) prescription drug advertising: The moderating role of subjective health literacy. Journal of Consumer Affairs, 48(1), 175–194. doi:10.1111/joca.12028
  • Aikin, K. J., & O’Donoghue, A. C. (2008). Toll-Free number for reporting adverse events on labeling for human drug products: Labeling comprehension study. Food and Drug Administration. Retrieved from https://www.regulations.gov/document?D=FDA-2003-N-0313-0009
  • Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs: Summary of FDA survey research results. Retrieved from https://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/UCM152860.pdf
  • Anderson, M., Perrin, A., & Jiang, J. (2018, March 5). 13% of Americans don’t use the internet: Who are they? Pew Research Center. Retrieved from http://www.pewresearch.org/fact-tank/2018/03/05/some-americans-dont-use-the-internet-who-are-they/
  • Betts, K. R., Boudewyns, V., Aikin, K. J., Squire, C., Dolina, S., Hayes, J. J., & Southwell, B. G. (2018). Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements. Research in Social and Administrative Pharmacy, 14, 951–963. doi:10.1016/j.sapharm.2017.07.015
  • Delorme, D. E., Huh, J., & Reid, L. N. (2010). Evaluation, use, and usefulness of prescription drug information sources among Anglo and Hispanic Americans. Journal of Health Communication, 15(1), 18–38. doi:10.1080/10810730903460526
  • Finucane, M. L., Slovic, P., Mertz, C. K., Flynn,J., & Satterfield, T. A. (2010). Gender, race and perceived risk: The ‘white-male’effect. Health, Risk & Society, 2(2), 159–172.
  • Food and Drug Administration (2017). Content and risk information in the major statement in prescription drug direct-to-consumer broadcast advertisements; Establishment of a public docket; Request for information and comments. 82 Federal Register 160, 39598.
  • Frosch, D. L., Grande, D., Tarn, D. M., & Kravitz, R. L. (2010). A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health, 100(1), 24–32. doi:10.2105/AJPH.2008.153767
  • Frosch, D. L., Krueger, P. M., Hornik, R. C., Cronholm, P. F., & Barg, F. K. (2007). Creating demand for prescription drugs: A content analysis of television direct-to-consumer advertising. The Annals of Family Medicine, 5(1), 6–13. doi:10.1370/afm.611
  • Hoek, J., Gendall, P., & Feetham, P. (2001). Could less be more? An analysis of direct to consumer advertising of prescription medicines. Marketing Bulletin, 12, 1–15.
  • Huh, J., Delorme, D. E., Reid, L. N., & Kim, J. (2014). Do Korean-Americans view drug advertisements differently than non-Hispanic White Americans?: Perceptions of direct-to-consumer media: How useful is the information they convey? Journal of Advertising Research, 54(3), 332–345. doi:10.2501/JAR-54-3-332-345
  • Kahn, U., & Kupor, D. M. (2017). Risk (mis)perception: When greater risk reduces risk valuation. Journal of Consumer Research, 43(5), 769–786. doi:10.1093/jcr/ucw058
  • Kelly, B. J., Rupert, D. J., Aikin, K. J., Sullivan, H. W., Johnson, M., Bann, C., … Peinado, S. (n.d.) Development and validation of prescription drug risk, efficacy, and benefit perception measures among patients.
  • Kim, S., Mayhorn, C. B., & Wogalter, M. S. (2010). Use of information sources referenced in and attitudes about televised DTC prescription drug advertisements. Proceedings of the Human Factors and Ergonomics Society Annual Meeting, 54(21), 1880–1884. doi:10.1177/154193121005402111
  • Lewis, V. A., Larson, B. K., McClurg, A. B., Boswell, R. G., & Fisher, E. S. (2012). The promise and peril of accountable care for vulnerable populations: A framework for overcoming obstacles. Health Affairs, 31(8), 1777–1785. doi:10.1377/hlthaff.2012.0490
  • O’Donoghue, A. C., Sullivan, H. W., Williams, P. A., Squire, C., Betts, K. R., Fitts Willoughby, J., & Parvanta, S. (2016). Consumers’ understanding of FDA approval requirements and composite scores in direct-to-consumer prescription drug print ads. Journal of Health Communication, 21(8), 927–934. doi:10.1080/10810730.2016.1179367
  • Riggs, D. L., Holdsworth, S. M., & McAvoy, D. R. (2004). Direct-to-consumer advertising: Developing evidence-based policy to improve retention and comprehension. Health Affairs, 23, 249–252. doi:10.1377/hlthaff.W4.249
  • Schwartz, L. M., & Woloshin, S. (2011). Communicating uncertainties about prescription drugs to the public: A national randomized trial. Annals of Internal Medicine, 171, 1463–1468. doi:10.1001/archinternmed.2011.396
  • Schwartz, L. M., Woloshin, S., & Welch, H. G. (2009). Using a drug facts box to communicate drug benefits and harms: Two randomized trials. Annals of Internal Medicine, 150(8), 516–527. doi:10.7326/0003-4819-150-8-200904210-00106
  • Sivanathan, N., & Kakkar, H. (2017). The unintended consequences of argument dilution in direct-to-consumer drug advertisements. Nature Human Behaviour, 1(11), 797. doi:10.1038/s41562-017-0223-1
  • US Department of Commerce. (2018). Computer and Internet Use in the United States. Retrieved from https://www.census.gov/content/census/en/library/publications/2018/acs/acs-39.html
  • Weinstein, N. D. (1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10(5), 481–500. doi:10.1007/BF00846146

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.